Cisen Pharmaceutical Co.,Ltd. — Investor Relations & Filings
About Cisen Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical Co.,Ltd. is a comprehensive enterprise dedicated to the research, development, production, and marketing of a diverse range of medicinal products. The company specializes in the manufacture of large-volume injections, small-volume injections, and solid oral dosage forms, including tablets and capsules. Its product portfolio addresses critical therapeutic areas such as parenteral nutrition, anti-infectives, cardiovascular health, and anesthesia. Cisen Pharmaceutical maintains an integrated value chain, producing both active pharmaceutical ingredients (APIs) and finished formulations. The organization emphasizes technological innovation and stringent quality management systems to ensure the efficacy and safety of its medical solutions. By leveraging advanced manufacturing capabilities and a robust distribution network, the company provides essential healthcare products to clinical institutions and medical providers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 辰欣药业股份有限公司董事会提名委员会工作细则(2025年10月修订) | 2025-10-28 | Chinese | |
| 辰欣药业股份有限公司第五届董事会第十次会议决议公告 | 2025-10-28 | Chinese | |
| 辰欣药业股份有限公司2025年半年度权益分派实施公告 | 2025-09-26 | Chinese | |
| 辰欣药业股份有限公司关于持股5%以上股东减持股份计划完成暨减持股份结果公告 | 2025-09-24 | Chinese | |
| 辰欣药业股份有限公司关于公司董事离任暨选举职工代表董事的公告 | 2025-09-23 | Chinese | |
| 辰欣药业股份有限公司关于持股5%以上的股东权益变动触及1%刻度的提示性公告 | 2025-09-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 37406246 | 辰欣药业股份有限公司董事会提名委员会工作细则(2025年10月修订) | 2025-10-28 | Chinese | ||
| 37406239 | 辰欣药业股份有限公司第五届董事会第十次会议决议公告 | 2025-10-28 | Chinese | ||
| 37406231 | 辰欣药业股份有限公司2025年半年度权益分派实施公告 | 2025-09-26 | Chinese | ||
| 37406219 | 辰欣药业股份有限公司关于持股5%以上股东减持股份计划完成暨减持股份结果公告 | 2025-09-24 | Chinese | ||
| 37406214 | 辰欣药业股份有限公司关于公司董事离任暨选举职工代表董事的公告 | 2025-09-23 | Chinese | ||
| 37406206 | 辰欣药业股份有限公司关于持股5%以上的股东权益变动触及1%刻度的提示性公告 | 2025-09-23 | Chinese | ||
| 37406198 | 辰欣药业股份有限公司关于取消职工代表监事的公告 | 2025-09-23 | Chinese | ||
| 37406186 | 山东国曜琴岛(济南)律师事务所关于辰欣药业股份有限公司2025年第二次临时股东大会的法律意见书 | 2025-09-16 | Chinese | ||
| 37406050 | 辰欣药业股份有限公司2025年第二次临时股东大会决议公告 | 2025-09-16 | Chinese | ||
| 37406039 | 辰欣药业股份有限公司2025年第二次临时股东大会会议资料 | 2025-09-09 | Chinese | ||
| 37406029 | 辰欣药业股份有限公司关于2025年半年度业绩暨现金分红说明会召开情况的公告 | 2025-09-02 | Chinese | ||
| 37406011 | 辰欣药业股份有限公司关于持股5%以上股东权益变动触及1%刻度的提示性公告 | 2025-08-31 | Chinese | ||
| 37406003 | 辰欣药业股份有限公司关于持股5%以上股东减持股份计划公告 | 2025-08-29 | Chinese | ||
| 37405996 | 辰欣药业股份有限公司总经理工作细则(2025年8月) | 2025-08-27 | Chinese | ||
| 37405987 | 辰欣药业股份有限公司董事和高级管理人员离职管理制度(2025年8月) | 2025-08-27 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Cisen Pharmaceutical Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57632/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57632 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57632 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57632 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57632}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cisen Pharmaceutical Co.,Ltd. (id: 57632)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.